📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Who will be eligible? An investigation of the dementia population eligible for cholinesterase treatment following the change in NICE guidance. (2010)

First Author: Matthews FE

Attributed to: Statistical modelling of cognitive decline to improve estimation, identifying risk factors and population benefits. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1002/gps.2413

PubMed Identifier: 19946863

Publication URI: http://europepmc.org/abstract/MED/19946863

Type: Journal Article/Review

Volume: 25

Parent Publication: International journal of geriatric psychiatry

Issue: 7

ISSN: 0885-6230